Pulse Biosciences Inc (PLSE)

Finanzdaten der Pulse Biosciences Inc-Aktie (PLSE)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Research and Development	13.57% 6.741	7.799	7.472	6.697	5.829
Costs And Expenses	15.30% 10.62	12.53	11.25	10.23	9.562
Operating Income/Loss	15.30% -10.62	-12.53	-11.25	-10.23	-9.562
Nonoperating Income/Loss	20.33% 0.478	0.60	0.686	0.317	-0.239
Income/Loss From Continuing Operations Before Tax	15.05% -10.14	-11.93	-10.57	-9.91	-9.801
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	15.05% -10.14	-11.93	-10.57	-9.91	-9.801
Net Income/Loss	15.05% -10.14	-11.93	-10.57	-9.91	-9.801
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,232% 55.17	2.366	54.92	44.51	37.39
Basic Earnings Per Share	18.18% -0.18	-0.22	-0.19	-0.22	-0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-